아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - amoxicillin; clavulanic acid - powder for solution for injection/infusion - 1000 mg/200 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

영국 - 영어 - myHealthbox

sandoz ltd - amoxicillin, clavulanic acid - powder for solution for injection of infusion - 1000/200mg - combinations of penicillins, incl. beta-lactamase inhibitors - for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1): • severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms) • acute exacerbations of chronic bronchitis (adequately diagnosed) • community acquired pneumonia • cystitis • pyelonephritis • skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis • bone and joint infections, in particular osteomyelitis • intra-abdominal infections • female genital infections. prophylaxis against infections associated with major surgical procedures in adults, such as those involving the: • gastrointestinal tract • pelvic cavity • head and neck • biliary tract surgery.

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - potassium clavulanate; amoxicillin trihydrate - oral suspension - 6.25mg/1ml ; 25mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - amoxicillin trihydrate; potassium clavulanate - oral suspension - 50mg/1ml ; 12.5mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - potassium clavulanate; amoxicillin trihydrate - oral tablet - 125mg ; 250mg